Altimmune Inc (NASDAQ:ALT) price closed lower on Monday, April 15, dropping -5.51% below its previous close.
A look at the daily price movement shows that the last close reads $7.99. The company’s 5Y monthly beta was ticking 0.06. Taking into account the 52-week price action we note that the stock hit a 52-week high of $14.84 and 52-week low of $2.09. The stock subtracted -24.69% on its value in the past month.
Altimmune Inc, which has a market valuation of $535.30 million, is expected to release its quarterly earnings report May 09, 2024 – May 13, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ALT a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that ALT’s price is at present -15.99% off the SMA20 and -22.66% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 36.75, with weekly volatility standing at 7.22%. The indicator jumps to 8.70% when calculated based on the past 30 days. Altimmune Inc (NASDAQ:ALT)’s beta value is holding at 0.13, while the average true range (ATR) indicator is currently reading 0.83.
An analysis of the Altimmune Inc (NASDAQ:ALT) stock in terms of its daily trading volume indicates that the 3-month average is 5.15 million.
Current records show that the company has 70.68M in outstanding shares. The insiders’ percentage holdings are 1.02% of outstanding shares while the percentage share held by institutions stands at 62.01%. But the -32.89% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
